8-KEarnings & ResultsExhibits & Filings

Elevance Health, Inc. 8-K Report, Financial Results (Jul 21, 2021)

Filed July 21, 2021For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on July 21, 2021, to report its financial results for the second quarter ended June 30, 2021. The filing primarily includes a press release detailing these results, which is furnished as an exhibit. Investors should note that the information provided in this 8-K, including the press release, is considered furnished and not filed for the purposes of Section 18 of the Securities Exchange Act of 1934, meaning it does not carry the same legal implications as a formally filed document regarding liability for misstatements or omissions. The report also contains forward-looking statements, which offer management's current expectations about future performance and operations. Investors are cautioned that these statements are subject to various risks and uncertainties that could cause actual results to differ materially. The company highlights potential impacts from public health emergencies, healthcare cost trends, regulatory changes (including the Affordable Care Act), economic conditions, competitive pressures, and operational risks, among others. While specific financial figures are not detailed in the 8-K text itself, the furnished press release would contain these critical performance indicators for the quarter.

Key Highlights

  • 1Elevance Health (Anthem, Inc.) announced its Q2 2021 financial results via an 8-K filing on July 21, 2021.
  • 2The primary content of the filing is a press release (Exhibit 99.1) detailing the company's financial performance for the quarter ended June 30, 2021.
  • 3Information furnished in this 8-K is not deemed 'filed' for legal liability purposes under Section 18 of the Securities Exchange Act of 1934.
  • 4The report includes standard forward-looking statements, cautioning investors about potential deviations from projected outcomes.
  • 5Key risk factors discussed include the impact of public health emergencies (like COVID-19), healthcare cost trends, and regulatory environments.
  • 6Other significant risks mentioned involve competitive pressures, provider contract negotiations, enrollment changes, and potential data privacy issues.
  • 7The filing also touches upon risks related to government programs (Medicare/Medicaid), quality ratings, PBM business, and potential litigation or investigations.

Frequently Asked Questions

The specific financial results for the quarter ended June 30, 2021, are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing. You would need to access the full filing to view this exhibit.

The 'furnished, not filed' designation means that while the information is being provided to the SEC and investors, it is not subject to the same liabilities under Section 18 of the Securities Exchange Act of 1934 as information that is formally 'filed'. This reduces the company's legal exposure to potential misstatements or omissions within that furnished information.

Elevance Health highlights a broad range of risks, including the impact of public health emergencies (such as COVID-19), fluctuations in healthcare costs and utilization, regulatory changes (especially concerning the ACA), economic downturns, competitive intensity, challenges in securing provider contracts, potential enrollment declines, and risks associated with their pharmacy benefit management (PBM) business, among others.

This 8-K filing primarily serves to report past financial results through a press release. While it contains forward-looking statements discussing expectations and potential future impacts, it does not explicitly provide updated financial guidance or outlook figures within the text of the 8-K itself. Such guidance would typically be found within the furnished press release or potentially in subsequent investor presentations or calls.